Wallst45 Posted - 7 hours ago

$AMGN new data tomorrow ??

emeraldbayrider Posted - 9 hours ago

$AMGN This should now quickly get back over the 4293 hurdle... and from their, it s/b the fast elevator to $313. I've put on 8k now, but likely to double here as it jumps past $293

TwoToesTrading Posted - 12 hours ago

Choose your own adventure They’re all printing 🔥🔥🔥🔥🔥 $AMZN $GOOGL $AMGN $YPF

Wallst45 Posted - 12 hours ago

$AMGN how do you know ??

SausageTrader Posted - 12 hours ago

$AMGN somebody knows something

Wallst45 Posted - 13 hours ago

$AMGN $XBI can they release data anytime ??

muldoon92 Posted - 13 hours ago

$AMGN some aggressive purchases of the 300 strike ending in 2 days? Wtf 😳 are they about to drop Maritide data on the market and burn shorts? $XBI

TwoToesTrading Posted - 13 hours ago

$AMGN the correct answer was…. YES ✅

Stocksrunner Posted - 13 hours ago

$AMGN trading at $284, support $278, resistance $325. patience might pay off here.

TwoToesTrading Posted - 14 hours ago

$AMGN think she prints?

EveryTimeICash Posted - 14 hours ago

$AMGN Boom goes the dynamite

clan Posted - 17 hours ago

$MNKD Mannkind Corp. revenues continue to grow. All hail Lasagna! $SNY $AMGN $BMY

Emoney999 Posted - 17 hours ago

$NTLA I have a feeling that management is complicit and is acting silent and with an even peace. Like they know something we don’t, even institutions are not selling. Insiders can’t buy because an acquisition is in the works. I would not be surprised that one of theses $REGN $AMGN $NVS acquired the company

Wenmoon6996 Posted - 1 day ago

$AMGN when is Martide data coming

biolover Posted - 1 day ago

$VKTX $AMGN One important take away from Brian Liam fire chat today IMHO Samimy: Okay. Some of the KOLs that we speak to not always just looking for a better GLP or a better GLP/GIP, but really are looking for something different, a different mechanism, a different, I don't know, something to treat a patient who won't respond to, say, a dual agonist or a GLP BL: Yes, it's a tough question. I mean people have been looking for weight loss drugs forever. So I worked at Amgen 20 years ago, and weight loss was a huge focus at that time. . So everybody talks about new mechanisms like they're really easy to find. It's pretty tough. And so we look at amylin as an interesting mechanism. I This point by KOLs indicate need for more potent glp1 gip agonists and this is what Viking has and its primary differentiating strength Amgen , much bigger company , still can’t find its way in obesity after all these years and despite management stating “ we are all in in obesity. “

SparkyReturns Posted - 1 day ago

@cluelessinvstor REGN should be through their 6 month stability period for the MAbs and we could hear any time now if they exercise their option to move forward in development; could be significant milestones and royalties but deal terms not disclosed yet. They could also potentially partner on their XP-8121 drug getting ready for Phase 3 soon. Meeting FDA on Ph 3 plan soon. Could also hear update on other collabs with AMGN and Beta Bionics, or a new collab any time. $REGN $AMGN $LLY $ABBV

NEWBIGTECH Posted - 1 day ago

$ESPR #BempedoicAcid and Limb Outcomes in Statin-Intolerant Patients with #Peripheral #Artery #Disease. #PAD a common condition in which narrowed #arteries #bloodflow to the arms or legs. $AMGN $JNJ #Stocks #News #BempedoicAcid #Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024 https://finance.yahoo.com/news/esperion-highlights-exploratory-data-clear-153000058.html

EveryTimeICash Posted - 1 day ago

$AMGN probably a little overdone

NEWBIGTECH Posted - 1 day ago

@nomalarkey talk on X. Also $AMGN

Quantumup Posted - 2 days ago

BMO Capital defends its Obesity names $LLY $NVO $AMGN $GPCR, says Step Away From the Computer and Breathe - RFK Jr. Comments Are Not End of GLP-1s 📝while RFK Jr. appears less optimistic on incretins, he remains limited in his ability2influence either policy or pricing: $VKTX TERN XBI

impact80 Posted - 2 days ago

$AMGN $250 soon

Capitulation_0 Posted - 2 days ago

$CGEM Aug 19: $MRK just bought CN201, a CD19xCD3 TCE from Curon for $700M cash plus up to $600M in milestones. Curon is China bio Oct 29: $GSK to acquire CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager, from Chimagen Biosciences for $300M upfront. Chimagen is China bio. $CGEM is in the lead as none of these have US IND. $AMGN, $LLY and others should be kicking tires on this.. EV $200m. What a steal.

cubie Posted - 2 days ago

only thing hold poots on, are the RFK cootie stonks $lly $nvo $amgn $vktx $mrk 🤭🫡

nio11 Posted - 2 days ago

$AMGN this is a difficult stock to be in. For no reason, you could have a nasty 5% drop... this just hit ex-div today to make to make $281, and yet in the pre market it went as low as $266!!! And this is after the Maritide news that analysts made no changes to their PT and the RFK news last week.

BuyHighSellLowGER Posted - 2 days ago

$AMGN What on earth is wrong with this stock? I mean I sold cash secured puts so of course there is a drop the next days but this is ridiculous.

profit_guru Posted - 2 days ago

$AMGN - why are options premiums so high this week.. any updates coming???

taurus_bullish Posted - 2 days ago

$AMGN great buying opportunity, cheap price

Monkey_Banana_Genius Posted - 2 days ago

$AMGN yep

DavyDaveCharts Posted - 3 days ago

$AMGN 2 Week chart: deep into a fair value gap, where it found a small bottom wick off of a volume shelf and a VWAP anchored to late May, 2023 lows. Watching for bottom here.

clan Posted - 3 days ago

$MNKD News potentially on: Afrezza (peds, switch, India), and/or Tyvaso Teton, and/or clofazimine, and/or nintedanib, and/or debt pay down that could cause MNKD to move +$3.11/sh before year end? "So, what you are saying is, there's still a chance." 10B4YE $lly $sny $amgn